LYTIR

Company · PYXS

Pyxis Oncology, Inc.

Nasdaq's symbol directory lists PYXS on Nasdaq as “Pyxis Oncology, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion (value not filed); insiders sold on 1 occasion ($107K); 6 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Dupont Jakob sold on 1 day all under a 10b5-1 plan latest Jun 30, 2026 sold $107K
  2. GordonMD Global Investments LP bought on 1 day latest Oct 1, 2026 value not filed
Every trade (2)
  1. BUYGordonMD Global Investments LP bought Oct 1, 2026 5,517,000 shares filing —
  2. SELLDupont Jakob sold Jun 30, 2026 35,000 shares 10b5-1 plan (scheduled) filing $107K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Laurion Capital Management LP filed Nov 3, 2026 Schedule 13G/A passive 4,300,888 shares filing 5.16%
  2. GordonMD Global Investments LP filed Oct 9, 2026 Schedule 13G/A passive filing 16.4%
  3. Coastlands Capital LP filed Oct 5, 2026 Schedule 13G passive filing 5.42%
  4. GordonMD Global Investments LP filed Oct 2, 2026 Schedule 13G/A passive filing 17.5%
  5. BIOTECHNOLOGY VALUE FUND L P filed Jul 10, 2026 Schedule 13G passive filing 5.5%
  6. GordonMD Global Investments LP filed Jul 2, 2026 Schedule 13G/A passive filing 12.1%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 5, 2026
  2. Entry into a material definitive agreement; Other events filing Oct 1, 2026
  3. Regulation FD disclosure; Other events filing Sep 9, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.